1509TiP The 1825-EORTC, ALKALINE: Activity of lorlatinib based on ALK resistance mutations on blood in ALK positive NSCLC patients previously treated with second generation ALK inhibitor.
Saved in:
| Title: | 1509TiP The 1825-EORTC, ALKALINE: Activity of lorlatinib based on ALK resistance mutations on blood in ALK positive NSCLC patients previously treated with second generation ALK inhibitor. |
|---|---|
| Authors: | Mezquita, L.1 (AUTHOR), Xenophontos, E.2 (AUTHOR), Pretzenbaher, Y.3 (AUTHOR), Sureda, C.4 (AUTHOR), Nadal, E.5 (AUTHOR), Al-Rabi, K.6 (AUTHOR), Rousseau Bussac, G.7 (AUTHOR), Ponce Aix, S.8 (AUTHOR), Sullivan, I.G.9 (AUTHOR), Calles Blanco, A.10 (AUTHOR), Cloarec, N.11 (AUTHOR), De Langen, J.12 (AUTHOR), Berghmans, T.13 (AUTHOR), Descourt, R.14 (AUTHOR), Hendriks, L.15 (AUTHOR), Garrido Lopez, P.16 (AUTHOR), Helland, A.17 (AUTHOR), Carcereny, E.18 (AUTHOR), Besse, B.19 (AUTHOR), Dingemans, A-M.C.20 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS849-S850. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173099260 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1509TiP The 1825-EORTC, ALKALINE: Activity of lorlatinib based on ALK resistance mutations on blood in ALK positive NSCLC patients previously treated with second generation ALK inhibitor. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mezquita%2C+L%2E%22">Mezquita, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xenophontos%2C+E%2E%22">Xenophontos, E.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pretzenbaher%2C+Y%2E%22">Pretzenbaher, Y.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sureda%2C+C%2E%22">Sureda, C.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nadal%2C+E%2E%22">Nadal, E.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Rabi%2C+K%2E%22">Al-Rabi, K.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rousseau+Bussac%2C+G%2E%22">Rousseau Bussac, G.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ponce+Aix%2C+S%2E%22">Ponce Aix, S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sullivan%2C+I%2EG%2E%22">Sullivan, I.G.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Calles+Blanco%2C+A%2E%22">Calles Blanco, A.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cloarec%2C+N%2E%22">Cloarec, N.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Langen%2C+J%2E%22">De Langen, J.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berghmans%2C+T%2E%22">Berghmans, T.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Descourt%2C+R%2E%22">Descourt, R.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hendriks%2C+L%2E%22">Hendriks, L.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garrido+Lopez%2C+P%2E%22">Garrido Lopez, P.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Helland%2C+A%2E%22">Helland, A.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carcereny%2C+E%2E%22">Carcereny, E.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Besse%2C+B%2E%22">Besse, B.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dingemans%2C+A-M%2EC%2E%22">Dingemans, A-M.C.</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS849-S850. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173099260 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.2540 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S849 Titles: – TitleFull: 1509TiP The 1825-EORTC, ALKALINE: Activity of lorlatinib based on ALK resistance mutations on blood in ALK positive NSCLC patients previously treated with second generation ALK inhibitor. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mezquita, L. – PersonEntity: Name: NameFull: Xenophontos, E. – PersonEntity: Name: NameFull: Pretzenbaher, Y. – PersonEntity: Name: NameFull: Sureda, C. – PersonEntity: Name: NameFull: Nadal, E. – PersonEntity: Name: NameFull: Al-Rabi, K. – PersonEntity: Name: NameFull: Rousseau Bussac, G. – PersonEntity: Name: NameFull: Ponce Aix, S. – PersonEntity: Name: NameFull: Sullivan, I.G. – PersonEntity: Name: NameFull: Calles Blanco, A. – PersonEntity: Name: NameFull: Cloarec, N. – PersonEntity: Name: NameFull: De Langen, J. – PersonEntity: Name: NameFull: Berghmans, T. – PersonEntity: Name: NameFull: Descourt, R. – PersonEntity: Name: NameFull: Hendriks, L. – PersonEntity: Name: NameFull: Garrido Lopez, P. – PersonEntity: Name: NameFull: Helland, A. – PersonEntity: Name: NameFull: Carcereny, E. – PersonEntity: Name: NameFull: Besse, B. – PersonEntity: Name: NameFull: Dingemans, A-M.C. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
